Speaker Faculty

Monideepa Roy

Vice President - Corporate, Research & Development

Actinium Pharmaceuticals

Eftychia Koumarianou

Director - Pre-clinical & Pharmacy

ABX-CRO

Stanley Satz

Chairman & Chief Scientific Officer

Advanced Innovative Partners

Andreas Kluge

Owner & Lead Consultant

ABX-CRO

Manfred Rüdiger

Chief Executive Officer & Managing Director

Ariceum Therapeutics

Jeff Kovacs

Head of Oncology Research

Aktvis Oncology

Urs Hagemann

Head of Targeted Radiopharmaceuticals- Research & Early Development Oncology

Bayer

Sheamus Gleason

Executive Vice President

Clarity Pharmaceuticals

Michael Zalutsky

Professor of Radiology & Director, Radiopharmaceutical Chemistry Laboratory

Duke University

Stig Palm

Researcher

Department of Radiation Physics

John Carney

Chief Executive Officer

itheranostics

Jean-François Gestin

Head of Chemistry & Radiochemistry

Inserm Lille Neuroscience & Cognition Research Centre

Friedmund Bachmann

Director - Chemistry, Manufacturing, Control & Biologics

OncoOne

Jan A. Alfheim

Chief Executive Officer

Oncoinvent

Chris Pak

President & Chief Executive Officer

Molecular Targeting Technologies

Cyril Berthet

Director of Pharmaco-Imaging Unit & MRT Department

Oncodesign SA

Adrien Reymond

Radiopharmaceuticals Expert Consultant

READ Pharma

Marc Robillard

Chief Executive Officer & Founder

Tagworks Pharmaceuticals

James Nagarajah

Assistant Professor

Radboudumc

Riccardo Canevari

Chief Executive Officer

Radiopharm Theranostics

Jakub Simecek

Chief Executive Officer

TRIMT

Lucy Morgan

Associate Director of Research & Policy

The Health Policy Partnership

Noble George

Sr Director Imaging Science & Operations

POINT Biopharma

Alex Jackson

Head of Research & Development

Theragnostics

Michael Schultz

Chief Science Officer

Viewpoint Molecular Targeting